Skip to content

Effectiveness of SRP+ Lipo-curcumin Gel for the Treatment of Stage III Periodontitis.

Clinical Evaluation of Lipo-Curcumin Gel in Association with SRP for the Treatment of Stage III Periodontitis: a Randomized and Controlled Clinical Trial.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06624241
Enrollment
40
Registered
2024-10-02
Start date
2024-06-12
Completion date
2025-09-30
Last updated
2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Attachment Loss, Periodontal Diseases, Periodontal Pocket

Keywords

Curcumin, SRP, Liposome, Periodontitis

Brief summary

The aim of the present study is to clinically and radiographically compare the effectivness of Scaling and Root Plannig (SRP) in association with lipo-curcumin gel (LC) respect SRP+ lipo-gel (L), SRP+ discharged (D) gel and SRP alone. This study will be designed as a randomized clinical trial of 12-month duration. A total of 40 patients will be recruited and randomly equally distributed into 4 groups: an experimental group treated with SRP + LC, a first control group treated with SRP + L, a second control group treated with SRP+D and a third control group SRP alone. Each defect will be treated with an ultrasonic scaler with dedicated thin tips for supra- and subgingival debridement associated with hand instrumentation under local anesthesia. Caution will be taken to preserve the stability of soft tissues. Following SRP, experimental and control sites will be randomly chosen. The test sites will be t filled with a Lipo-Curcumin gel and sealed with cyanoacrylate. In the first control group the defects will be be filled with a Lipo gel and sealed with cyanoacrylate. In the second control sites he pocket defect will be filled with a discharged gel and sealed with cyanoacrylate, in the third control group SRP alone will be performed. Pre- and post-treatment clinical measurements were performed by an examiner blinded to the treatment modalities using a graded periodontal probe (HuFriedy UNC 15). Before the treatment and at 6 and 12 months post-treatment, all patients were examined by measuring the clinical attachment level, probing depth, gingival recession, full-mouth plaque score and bleeding on probing.

Interventions

PROCEDURELipo-Curcumin gel + SRP

The pocket defect will be debrided with the use of fine ultrasonic tips and mini hand instruments and will be treated with the application of Lipo- Curcumin gel. The pocket will be sealed with cyanoacrylate.

PROCEDURELipo gel + SRP

The pocket defect will be debrided with the use of fine ultrasonic tips and mini hand instruments and will be treated with the application of Lipo gel. The pocket will be sealed with cyanoacrylate.

PROCEDUREDischarged Gel + SRP

The pocket defect will be debrided with the use of fine ultrasonic tips and mini hand instruments and will be treated with the application of discharged gel. The pocket will be sealed with cyanoacrylate.

PROCEDURESRP alone

The pocket defect will only be debrided with the use of fine ultrasound tips and mini hand instruments and no further treatment will be performed.

Sponsors

G. d'Annunzio University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with a diagnosis of periodontitis stage III (grades A to C) * on-smokers or former smokers who quit at least 1 year ago, and had not received any periodontal treatment in the 3 months prior to recruitment * FMPS \< 20% at baseline * Furcation not involved * Not Pregnant or Lactating * Signed informed consent

Exclusion criteria

* Presence of uncontrolled systemic diseases that could affect treatment outcomes such as diabetes mellitus with an HbA1C\>7%, rheumatoid arthritis or any form of immunosuppression * Patients that had received systemic or local delivery of antibiotic therapy 6 weeks before enrollment * Chronic intake of NSAIDs or steroids, currently

Design outcomes

Primary

MeasureTime frameDescription
Pocket Probing Depth (PPD)12 monthsDistance between the gingival margin and the bottom of the pocket.

Secondary

MeasureTime frameDescription
Clinical Attachment Level (CAL)12 monthsDistance between the CEJ and the bottom of the pocket
Gingival Recession (GR)12 monthsDistance between the CEJ and the gingival margin.
Full Mouth Plaque Score12 monthsIndex that evaluates the general presence of bacterial plaque for all teeth. Through the passage of the probe, the presence of plaque deposits is reported for 4 surfaces for each tooth. A ratio is made between the contaminated surfaces and the total surfaces investigated to obtain a percentage value.
Full Mouth Bleeding Score12 monthsIndex that evaluates the general presence of bleeding for all teeth. Through the insertion of a periodontal probe, the presence of bleeding on probing is signaled for 4 sites for each tooth. A ratio is made between the bleeding sites and the total sites investigated to obtain a percentage value.

Countries

Italy

Contacts

Primary ContactMichele Paolantonio, DDS, MD
michelepaolantonio@gmail.com3395204073

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026